Invesco Ltd. Instil Bio, Inc. Call Options Transaction History
Invesco Ltd.
- $499 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TIL
# of Institutions
2Shares Held
1.9MCall Options Held
0Put Options Held
0About Instil Bio, Inc.
- Ticker TIL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 129,694,000
- Market Cap $2.82B
- Description
- Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...